Dr Rama Gitifar

Dr Rama Gitifar is Adjutor’s Head of Development, Regulatory & Commercialisation and a regulatory affairs expert with more than twenty years’ experience in shaping development and regulatory strategies for medicines, biologics and advanced therapies. She specialises in designing strategies that support early registrations, meaningful therapeutic use and sustainable competitive positioning in the market.
 
Her experience includes accelerated and collaborative pathways, complex benefit–risk negotiations and evidence strategies for products progressing in evolving or non-traditional data environments. Rama is known for her clarity in decision-making and her structured, solutions-oriented approach to resolving scientific and regulatory uncertainty, identifying early the issues that determine approval outcomes and real-world therapeutic use. Her early experience within a Health Authority enables strategies that anticipate regulator priorities, minimise risk early and preserve momentum and market opportunity.
 
She brings a balanced combination of scientific depth and commercial awareness, supporting teams to navigate regulatory inflection points efficiently while safeguarding label scope, market opportunity and sustained patient access.